Browse Items (1 total)

Tags: Streptococcus pneumoniae/drug effects/isolation & purification

Sort by:

Title
Creator
Date Added

Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia.

Streptococcus pneumoniae, the most important respiratory tract pathogen implicated in community-acquired pneumonia (CAP), is becoming increasingly resistant in vitro to the beta -lactams and macrolides, and fluoroquinolone resistance has been…

Tags: 2004, Anti-Infective Agents/*therapeutic use, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Community-Acquired Infections/*drug therapy/microbiology, Department of Internal Medicine, File Thomas M Jr, Humans, NEOMED College of Medicine, Pneumonia/*drug therapy/microbiology, Streptococcus pneumoniae/drug effects/isolation & purification, Treatment Outcome

Output Formats

atom, dcmes-xml, json, omeka-xml, rss2